Myelopeptide-2 (MP-2) Mechanisms, Clinical Applications, and

2025-09-18

Rucaparib (AG-014699): Mechanisms and Models for Radiosen...

2025-09-18

Explore the mechanistic underpinnings of Rucaparib (AG-014699, PF-01367338), a potent PARP inhibitor, as a radiosensitizer for prostate cancer cells in DNA damage response research. This article examines the intersection of

Papain Inhibitor Mechanisms, Clinical Applications, and

2025-09-17

Dynorphin (2-17), Amide, Porcine Mechanistic Insights, Clini

2025-09-16

Research-Oriented Review of ANP (1-11), rat Mechanisms, Clin

2025-09-15

Pharmacological Profile and Research Applications of a-MSH,

2025-09-13

Amyloid β-Peptide (10-20) (human) Mechanistic Insights, Clin

2025-09-12

Gap 27 A Connexin43 Mimetic Peptide for Modulation of Gap Ju

2025-09-11

Amyloid β-Peptide (10-20) (Human) Mechanisms, Clinical Appli

2025-09-10

Cadherin Peptide, Avian Mechanisms, Clinical Applications, a

2025-09-09

b-Casomorphin (1-3) Mechanisms, Clinical Applications, and R

2025-09-08

Amyloid Precursor C-Terminal Peptide Mechanisms, Clinical Va

2025-09-05

LEP (116-130) (mouse) Mechanistic Insights, Clinical Value,

2025-09-04

Papain Inhibitor Mechanisms, Clinical Applications, and Rese

2025-09-03

Adrenorphin, Free Acid Mechanistic Insights, Clinical Value,

2025-09-02